Form 4 for HBIO HARVARD BIOSCIENCE INC
Accepted 2022-01-03 00:00:00 ET · period of report 2022-01-01 · accession 0000921895-22-000032 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2022-01-03 | 2022-01-01 | HBIO | Green James W | CEO, Dir | F - Tax | $7.05 | -47.4K | 1.98M | -2% | -$334.3K |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2022-01-01 | F | D | 47,424 | $7.05 | 1,977,554 | D | — | — | (F1) The shares were disposed of to satisfy the Reporting Person's tax withholding obligation in connection with a restricted stock unit award previously granted to the Reporting Person which vested in part on January 1, 2022. (F2) Includes (a) 218,141 remaining restricted stock units that will vest on June 11, 2022 and 2023, (b) 129,799 restricted stock units that will vest in two equal installments on December 29, 2022 and 2023, (c) 109,070 remaining restricted stock units that will vest on December 29, 2022 and 2023, (d) 104,590 remaining restricted stock units that will vest on January 1, 2023, (e) 605,035 restricted stock units with performance based vesting conditions tied to relative total shareholder return, and (f) 810,919 shares of common stock beneficially owned by the Reporting Person. |